- Home
- PBYI vs BAER Comparison
PBYI vs BAER Comparison
Compare PBYI & BAER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- BAER
- Stock Information
- Founded
- PBYI 2010
- BAER 2014
- Country
- PBYI United States
- BAER United States
- Employees
- PBYI N/A
- BAER N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- BAER Blank Checks
- Sector
- PBYI Health Care
- BAER Finance
- Exchange
- PBYI Nasdaq
- BAER Nasdaq
- Market Cap
- PBYI 126.5M
- BAER 115.9M
- IPO Year
- PBYI N/A
- BAER N/A
- Fundamental
- Price
- PBYI $2.65
- BAER $2.12
- Analyst Decision
- PBYI Strong Buy
- BAER Strong Buy
- Analyst Count
- PBYI 1
- BAER 1
- Target Price
- PBYI $7.00
- BAER $5.25
- AVG Volume (30 Days)
- PBYI 303.9K
- BAER 172.8K
- Earning Date
- PBYI 10-31-2024
- BAER 11-11-2024
- Dividend Yield
- PBYI N/A
- BAER N/A
- EPS Growth
- PBYI N/A
- BAER N/A
- EPS
- PBYI 0.18
- BAER N/A
- Revenue
- PBYI $219,143,000.00
- BAER $73,248,000.00
- Revenue This Year
- PBYI N/A
- BAER $26.61
- Revenue Next Year
- PBYI N/A
- BAER N/A
- P/E Ratio
- PBYI $14.56
- BAER N/A
- Revenue Growth
- PBYI N/A
- BAER 60.82
- 52 Week Low
- PBYI $2.13
- BAER $1.71
- 52 Week High
- PBYI $7.73
- BAER $7.82
- Technical
- Relative Strength Index (RSI)
- PBYI 52.38
- BAER 40.07
- Support Level
- PBYI $2.41
- BAER $2.01
- Resistance Level
- PBYI $2.69
- BAER $2.82
- Average True Range (ATR)
- PBYI 0.14
- BAER 0.24
- MACD
- PBYI 0.03
- BAER -0.01
- Stochastic Oscillator
- PBYI 85.71
- BAER 12.64
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About BAER Bridger Aerospace Group Holdings Inc.
Bridger Aerospace Group Holdings Inc operates as an aerial firefighting company. It provides aerial wildfire surveillance, relief and suppression, and aerial firefighting services using next-generation technology and environmentally friendly and sustainable firefighting methods. Bridger Aerospace provides aerial firefighting and wildfire management services to federal and state government agencies, including the United States Forest Service, across the nation. The company's portfolio is organized across two offerings: Fire Suppression, which Consists of deploying specialized Viking CL-415EAF ("Super Scooper") aircraft to drop large amounts of water quickly and directly on wildfires, and Aerial Surveillance, providing aerial surveillance via manned aircraft for fire suppression aircraft.